Search clinical trials for: Falciaparum
Total 1 results
-
University of KhartoumUniversity of Kassala, Sudan; Kassala; SudanUnknown
Sponsors and Collaborators
- Korea Otsuka International Asia Arab
- Sudimplant SAS - Groupe TBR
- Eurotrials Brasil Consultores Cientificos Ltda
- United States Department of Defense (DOD)
- S-Biotek Holding ApS
- Paulo Sérgio Gomes Nogueira Borges
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Oblikue Consulting
- Iyad Naeem Muhammad, PhD
- Lilly PharmaceuticalCompany
- University of Applied Sciences Jena
- Arsha Vidya Tirtha
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Plethora Solutions Ltd
- Foshan Sanshui District People's Hospital
- Julian Taylor Green
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Rivierduinen, Centre for Personality disorders Jelgersma
- Gunkang Pharmaceuticals, Inc
- View Full List
Medical Conditions
- Brain Tumor, Primary
- Advance Directive Completion
- Chemotherapy-Induced Neutropenia
- Testicular Teratoma
- Huntington Chorea
- Malaria,Falciparum
- Visual Attention Span Deficit
- Hypothermia Following Anesthesia, Sequela
- Thyroid and Parathyroid Surgery
- Vibration; Exposure
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Anemia Acute
- Immunologically-induced Lung Disease
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Puberty, Delayed
- Deformity Flexion
- Serum Albumin Low
- Gray Platelet Syndrome
- Blepharospasm of Both Eyelids
- View Full List
Drug Interventions
- Cyanoacrylate
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Bimatoprost 0.03% eye drops
- F520
- ABY-035 i.v.
- Sorafenib
- Vosaroxin
- Pemetrexed
- Celecoxib
- Rovalpituzumab tesirine
- MMV390048 120mg
- Standard medical therapy
- Cytisine
- Pegfilgrastim
- Oxycodone
- Mineralocorticoid receptor antagonist
- Acalabrutinib in combination with VR
- Ebselen
- Furmonertinib 160 mg
- S-Adenosyl-Methionine
- View Full List
CROs by country
- Contract Research Organizations in Colombia
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Finland
- Contract Research Organizations in Gambia
- Contract Research Organizations in Greece
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Jordan
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Russia
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Vietnam
- Contract Research Organizations in Zambia
- Contract Research Organizations in Zimbabwe
- CRO list by country